Search Page

1

Cite

Share

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.

Hahn BH, Grossman J, Chen W, McMahon M. Hahn BH, et al. Among authors: mcmahon m. J Autoimmun. 2007 Mar-May;28(2-3):69-75. doi: 10.1016/j.jaut.2007.02.004. Epub 2007 Apr 16. J Autoimmun. 2007. PMID: 17433865 Review.

Cite

Share

2

Cite

Share

Safety of tumour necrosis factor-alpha antagonists.

Khanna D, McMahon M, Furst DE. Khanna D, et al. Among authors: mcmahon m. Drug Saf. 2004;27(5):307-24. doi: 10.2165/00002018-200427050-00003. Drug Saf. 2004. PMID: 15061685 Review.

Cite

Share

3

Cite

Share

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.

McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH. McMahon M, et al. Arthritis Rheum. 2006 Aug;54(8):2541-9. doi: 10.1002/art.21976. Arthritis Rheum. 2006. PMID: 16868975

Cite

Share

4

Cite

Share

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP. Feng X, et al. Among authors: mcmahon m. Arthritis Rheum. 2006 Sep;54(9):2951-62. doi: 10.1002/art.22044. Arthritis Rheum. 2006. PMID: 16947629

Cite

Share

5

Cite

Share

Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.

Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, Paulus HE, Park GS, Gong T, Ansell BJ. Charles-Schoeman C, et al. Among authors: mcmahon m. J Rheumatol. 2007 Jul;34(7):1459-64. Epub 2007 Jun 1. J Rheumatol. 2007. PMID: 17552046 Clinical Trial.

Cite

Share

6

Cite

Share

Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.

McMahon M, Hahn BH. McMahon M, et al. Curr Opin Immunol. 2007 Dec;19(6):633-9. doi: 10.1016/j.coi.2007.11.001. Curr Opin Immunol. 2007. PMID: 18083018 Free PMC article. Review.

Cite

Share

7

Cite

Share

Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.

Hahn BH, McMahon M. Hahn BH, et al. Among authors: mcmahon m. Lupus. 2008 May;17(5):368-70. doi: 10.1177/0961203308089989. Lupus. 2008. PMID: 18490409 Review.

Cite

Share

8

Cite

Share

Inflammatory lipids as a target for therapy in the rheumatic diseases.

McMahon M, Brahn E. McMahon M, et al. Expert Opin Investig Drugs. 2008 Aug;17(8):1213-24. doi: 10.1517/13543784.17.8.1213. Expert Opin Investig Drugs. 2008. PMID: 18616417 Review.

Cite

Share

9

Cite

Share

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M. Hahn BH, et al. Among authors: mcmahon m. Arthritis Res Ther. 2008;10(4):213. doi: 10.1186/ar2471. Epub 2008 Aug 29. Arthritis Res Ther. 2008. PMID: 18828865 Free PMC article. Review.

Cite

Share

10

Cite

Share

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.

McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N, Charles-Schoeman C, Watson K, Wong WK, Volkmann E, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH. McMahon M, et al. Arthritis Rheum. 2009 Aug;60(8):2428-37. doi: 10.1002/art.24677. Arthritis Rheum. 2009. PMID: 19644959 Free PMC article.

Cite

Share